Perillyl Alcohol Conjugate Downregulates O6-Methylguanin DNA Methltransferase Via Inducing Ubiquitination-De

Total Page:16

File Type:pdf, Size:1020Kb

Perillyl Alcohol Conjugate Downregulates O6-Methylguanin DNA Methltransferase Via Inducing Ubiquitination-De Song et al. Cell Death and Disease (2018) 9:202 DOI 10.1038/s41419-017-0193-2 Cell Death & Disease ARTICLE Open Access Temozolomide–perillyl alcohol conjugate downregulates O6- methylguanin DNA methltransferase via inducing ubiquitination-dependent proteolysis in non-small cell lung cancer Xingguo Song1,LiXie1,2,MinghuiChang2,3,XinranGeng4,XingwuWang1,ThomasC.Chen5 and Xianrang Song 1,2 Abstract The DNA repair enzyme O6-methylguanin-DNA-methltransferase (MGMT) is able to remove products of alkylating agent such as O6-meG and emerges as a central determinant of cancer resistance to temozolomide (TMZ). Temozolomide–perillyl alcohol conjugate (TMZ–POH), a novel TMZ analog developed based on the conjugation of TMZ and POH, displayed strong anticancer potency in multiple cancer types, but seemed not to experience the chemoresistance even in cells with high MGMT expression unlike TMZ and other alkylating agents. In this study, we demonstrated TMZ–POH inhibited MGMT dependent on proteasomal pathway and this inhibition is a significant factor in its toxic effect in the non-small cell lung cancer (NSCLC) cells. 1234567890():,; 1234567890():,; Introduction such as O6-methyl-guanine (O6-meG), which trigger cell Nowadays, chemotherapy has been traditionally con- cycle-dependent DNA damage and cell death4. Although sidered as one of the standard treatment options for TMZ chemotherapy may enhance survival of cancer cancer patients, but the chemoresistance dramatically patients, intrinsic or acquired resistance to TMZ is also hinders its clinical application, especially for alkylating common and accounts for many treatment failures5, agents like temozolomide (TMZ)1. TMZ, an imidazote- because TMZ-induced DNA alkylation damage can be trazine derivative of the alkylating agent dacarbazine, was repaired by O6-methylguanin-DNA-methltransferase approved by the US FDA (Food and Drug Administration) (MGMT)6. and European Union2. Its cytotoxicity is mainly due to its MGMT, an evolutionary conserved enzyme whose high capability to react with DNA to form methyl adducts3, expression indicates poor prognosis in multiple cancers7, plays a crucial role in the defense against alkylating agents8. MGMT is able to remove O6-meG which cova- 9 Correspondence: Xianrang Song ([email protected]) lently is attached to the protein and inactivates it , and 1Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer emerges as a central determinant of tumor resistance to fi Hospital Af liated to Shandong University, Shandong Academy of Medical alkylating agents. Ongoing studies have intended to Sciences, Jinan, Shandong, China 2Department of Clinical Laboratory, Shandong Cancer Hospital Affiliated to inhibit MGMT activity to enhance the therapeutic effect Shandong University, Shandong Academy of Medical Sciences, Jinan, of TMZ10. Despite the development and application Shandong, China of many MGMT inhibitors including O6-benzylguanine Full list of author information is available at the end of the article Xingguo Song and Li Xie contributed equally to this work Edited by A. Stephanou © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a linktotheCreativeCommons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Official journal of the Cell Death Differentiation Association Song et al. Cell Death and Disease (2018) 9:202 Page 2 of 10 (O6-BG)11, lomeguatrib12, and their corresponding deri- in A549, SPC-A1, and H460 cells. TMZ–POH treatment vatives, the efficacy of MGMT inhibitors combined with resulted in endogenous MGMT protein downregulation alkylating agents remains controversial due to their compared to its individual constituents and their combi- – hematologic toxicity and inefficiency13 15. nation (Fig. 1b). Moreover, H520 was employed and TMZ–perillyl alcohol conjugate (TMZ–POH), a novel subject to infection of recombinant adenoviral vector TMZ analog16, is developed based on the conjugation of carrying the human MGMT gene (Ad-MGMT). Although TMZ and POH, the latter is a naturally occurring adenoviral infection led to sustained MGMT expression, monoterpene which has the amazing capability to TMZ–POH downregulated the exogenous MGMT pro- enhance the cytotoxicity of TMZ in several tumors17. tein after 48 and 72 h of treatment significantly (Fig. 1c). Previous studies had revealed that TMZ–POH displayed In addition, the phenomenon TMZ–POH-inhibited stronger anticancer potency than its individual con- MGMT protein expression was also observed in other stituents to several types of malignancy such as triple- cancer-derived cells, including ovarian carcinoma-derived negative breast cancer (TNBC)16, non-small cell lung cell A2780, human NPC-derived cell lines CNE2, and cancer (NSCLC)18, human nasopharyngeal carcinoma glioma-derived cell line T98G as shown in Figure S1. (NPC)19, and even TMZ-resistant gliomas20. Unlike TMZ These results suggest TMZ–POH inhibited both endo- and other alkylating agents, TMZ–POH seems not to genous and exogenous MGMT protein, independent of experience the chemoresistance even in cells with high cell type. MGMT expression. To illuminate this issue, in this study Besides, A549 and SPC-A1 cells were exposed to we aimed to explore the mechanisms of TMZ–POH- TMZ–POH with different concentrations, and MGMT regulating MGMT. protein level was detected. As shown in Fig. 1d, MGMT Accumulating evidences prove that MGMT is regulated protein was not affected by low concentration (12.5 and by multiple mechanisms. MGMT is epigenetically 25 μM) of TMZ–POH, but suppressed significantly by silenced by its promoter methylation in many cancer high concentration (50 and 100 μM) TMZ–POH, indi- types21,22, and its expression is regulated by Wnt/β-cate- cating TMZ–POH-downregulated MGMT dependent on nin signaling as the direct transcriptional target of β- concentration. In addition, we delineated the appropriate catenin7. Besides, MGMT protein can be modified by time for TMZ–POH treatments following MGMT multiple pathways. In mammals, it is a short-lived protein, downregulation. The presence of 100 µM TMZ–POH degraded via ubiquitination-dependent proteolysis23, and caused a significant decrease of MGMT protein from 12 h acts as a proteolytic target for the E6 human papilloma until 24 h in A549 and SPC-A1 cells (Fig. 1e). It has been virus oncoprotein24. In yeast, MGMT is a physiological reported that MGMT performs a stoichiometric reaction substrate of both the Ubr1-dependent N-end rule path- to accomplish the DNA repair and is inactivated and way and the Ufd4-dependent Ub fusion degradation degraded, it is not recycled to its active form but restored (UFD) pathway25. due to fresh translation in cells26,27. Therefore, Given the importance and complicated regulation of TMZ–POH was withdrawn to allow MGMT regeneration MGMT, in this paper we focused on the role of TMZ–POH for another 24, 48, and 72 h after incubation for 24 h, and in MGMT regulation, and that of MGMT in TMZ–POH’s then MGMT protein levels were analyzed by western blot. cytotoxicity in multiple cancer cells. We show that As expected, MGMT protein level was restored when TMZ–POH inhibits MGMT dependent on proteasomal TMZ–POH was evacuated (Fig. 1e), suggesting pathway and this inhibition is a significant factor in its toxic TMZ–POH functioned as a transient inhibitor of MGMT. effect in NSCLC cells, thus proposing TMZ–POH as a Taken together, our data support TMZ–POH down- potential therapeutic candidate for NSCLC. regulates MGMT in a concentration and time-dependent manner. Results TMZ–POH downregulates MGMT protein in a MGMT downregulation is required for TMZ–POH’s concentration and time-dependent manner cytotoxicity In order to illuminate the effect of TMZ–POH on Our previous study has revealed that TMZ–POH MGMT protein, we detected MGMT protein expression exhibited its cytotoxic effect on NSCLC18. To explore the in four different NSCLC cell, including A549, SPC-A1, influence of MGMT on TMZ–POH’s cytotoxicity, O6- NCI-H460, and NCI-H520. As shown Fig. 1a, A549, SPC- benzylguanine (O6-BG), an established inhibitor of A1, and NCI-H460 expressed high level of MGMT pro- MGMT and currently undergoing clinical trials15, was tein whereas H520 expressed low. Next, endogenous administrated and combined with TMZ–POH. Cell via- MGMT protein level followed by 100 μM TMZ, POH, bility was assayed by the MT assay. As shown in Fig. 2a, TMZ + POH (100 μM TMZ plus 100 μM POH), combination of TMZ–POH (50 and 100 μM) and O6-BG TMZ–POH or DMSO for 48 h, respectively, was detected (25 μM) suppressed cell proliferation in A549 and SPC-A1 Official journal of the Cell Death Differentiation Association Song et al. Cell Death and Disease (2018) 9:202 Page 3 of 10 Fig. 1 TMZ–POH downregulates MGMT protein in a concentration-dependent and time-dependent manner. a MGMT protein level was evaluated by western blots in A549, SPC-A1, H460, and H520 cells. b MGMT protein level was detected in A549, SPC-A1, and H460 cells following treatment with 100 μM TMZ, POH, TMZ + POH (100 μM TMZ + 100 μM POH), TMZ–POH, or DMSO for 48 h, respectively. c H520 cells were infected by Ad-MGMT or control for 24 h followed by 100 μM TMZ–POH treatment for indicated time. MGMT protein level was detected by western blots.
Recommended publications
  • Annual Report 2019 X
    CHAPTER I Definition 2 CHAPTER XI Corporate Governance Report 102 CHAPTER II Risk Warnings 5 I. Overview of Corporate Governance 102 CHAPTER III Company Profile 6 II. General Meeting 102 I. Profile 6 III. Performance of the Directors 104 II. History 9 IV. Work Performance of Board of Directors and 111 III. Staff Profile 11 Special Committees IV. Brief Introduction of the Organs and Branches 12 V. Chairman and General Manager 123 V. Basic Information about the Industry in Which the 16 VI. Securities Transactions by the Directors, Supervisors and 125 Company Operates Senior Management VI. Business Briefings of the Company 16 VII. Performance of Duties by Independent Non-executive 125 VII. Briefings of our Subsidiaries 17 Directors VIII. Honours Awarded to the Company During the 18 VIII. Supervision on Risk Management and Internal Control 125 Reporting Period System CHAPTER IV Financial Summary 20 IX. Other Relevant Matters 128 I. Major Accounting Data of the Group 20 CHAPTER XII Internal Control 133 II. Major Financial Indexes of the Group 20 I. Establishment of Internal Control Structure 133 III. Net Capital of the Company and Relevant Risk Control 21 II. Implementation and Operation of Internal Control System 133 Indicators III. Supervision and Inspection of Internal Control 133 IV. Financial Conditions of the Group of the Latest Five Years 22 IV. Conclusion of the Assessment of Internal Control 134 CHAPTER V Chairman Statement 23 CHAPTER XIII Independent Auditor’s Report 135 CHAPTER VI Management Discussion and Analysis 25 CHAPTER XIV Notes to the Consolidated Financial 140 I. Economic and Futures Market Analysis during the 25 Statements Reporting Period Consolidated Statements of Comprehensive Income 140 II.
    [Show full text]
  • Table of Codes for Each Court of Each Level
    Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115
    [Show full text]
  • Shandong Dezhou Investment Delegation to ASEAN
    Shandong Dezhou Investment Delegation to ASEAN CONTENTS Social and Economic Survey of Dezhou………………………………………………………………………….2 Competitive Industry of Dezhou....…………………………………………………………………………………4 CCPIT Dezhou Branch & CCIOC Dezhou Chamber…………………………………………………………..9 Shandong Dexing Group Construction Engineering Co., Ltd…………………………………………..11 Shandong Huahai Group Co., Ltd…………………………………………………………………………………13 Shandong Xin jiekou Culturaland Creative Industrial Zone …………………………………………..15 Shandong K.D.L. Textile Co., Ltd…..………………………………………………………………………………17 Dezhou Liyuan International Co.,Ltd……………………………………………………………………………19 Dezhou Huaqiang Trade Co. Ltd.………………………………………………………………………………….21 Shandong Dexing Group Gear Logistics Co., Ltd……………………………………………………………23 Hebei Dongfang Iron Tower Co., Ltd…………………….………………………………………………………25 LiuShun Automation Equipment Co., Ltd.………………………………………………………………….....27 Dezhou Huizhong Automobile Sales Co. Ltd. ………………………………………………………………..29 Leling Derum Health Food Co., Ltd…………………………………………………………………………........31 Shandong Yichang Lighting Technology Co, Ltd……………………………………………………….......33 Shandong Jitai Welding Materials Co., Ltd……………………………………………………………………35 Shandong Derun New Material Technology Co., Ltd…………………………………….……………….37 Shandong Fuyang Biotechnology Co., Ltd ……………………………………………………………………39 Ji'nan Hua Kaiyuan Co., Ltd………………………………………………………………………………………...41 Shandong HuaQiang New Material Co., Ltd………………………………………………………………….43 China Huayang Economic and Trade Group Co., Ltd. (HuayangGroup)……………………………………………………………………………………………………….45 1 Social
    [Show full text]
  • 2012 Annual Report 2017-10-17
    www.cs.ecitic.com (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (STOCK CODE : 6030) 2012 ANNUAL REPORT This annual report is printed on environmental paper. IMPORTANT NOTICE The Board and the supervisory committee of the Company and the Directors, Supervisors and Senior Management warrant the truthfulness, accuracy and completeness of the report and that there is no false representation, misleading statement contained herein or material omission from this report, and for which they will assume joint and several liabilities. This report was considered and approved at the 11th Meeting of the 5th Session of the Board of the Company. All Directors of the Company attended the meeting. No Director or Supervisor submitted any objection to this report. The Company’s 2012 profi t distribution proposal considered by the Board is a cash dividend of RMB3.00 for every 10 shares (tax inclusive), and is subject to the approval of the general meeting of the Company. The domestic and international annual fi nancial reports of the Company were audited by Ernst & Young Hua Ming LLP and Ernst & Young respectively, and auditor’s reports with standard unqualifi ed audit opinions were issued accordingly. Mr. WANG Dongming, Chairman of the Company, and Mr. GE Xiaobo, the person-in-charge of accounting affairs and the head of the Company’s fi nancial department, warrant that the fi nancial statements set out in this annual report are true, accurate and complete. There was no appropriation of funds of the Company by connected parties for non-operating purposes.
    [Show full text]
  • Annual Report 2019 Annual Report
    Annual Report 2019 Annual Report 2019 For more information, please refer to : CONTENTS DEFINITIONS 2 Section I Important Notes 5 Section II Company Profile and Major Financial Information 6 Section III Company Business Overview 18 Section IV Discussion and Analysis on Operation 22 Section V Directors’ Report 61 Section VI Other Significant Events 76 Section VII Changes in Shares and Information on Shareholders 93 Section VIII Directors, Supervisors, Senior Management and Staff 99 Section IX Corporate Governance Report 119 Section X Independent Auditor’s Report 145 Section XI Consolidated Financial Statements 151 Appendix I Information on Securities Branches 276 Appendix II Information on Branch Offices 306 China Galaxy Securities Co., Ltd. Annual Report 2019 1 DEFINITIONS “A Share(s)” domestic shares in the share capital of the Company with a nominal value of RMB1.00 each, which is (are) listed on the SSE, subscribed for and traded in Renminbi “Articles of Association” the articles of association of the Company (as amended from time to time) “Board” or “Board of Directors” the board of Directors of the Company “CG Code” Corporate Governance Code and Corporate Governance Report set out in Appendix 14 to the Stock Exchange Listing Rules “Company”, “we” or “us” China Galaxy Securities Co., Ltd.(中國銀河證券股份有限公司), a joint stock limited company incorporated in the PRC on 26 January 2007, whose H Shares are listed on the Hong Kong Stock Exchange (Stock Code: 06881), the A Shares of which are listed on the SSE (Stock Code: 601881) “Company Law”
    [Show full text]
  • Original Article Changes in Neurochemical Metabolism Measured by Magnetic Resonance Spectroscopy and Expression of the ERK Sign
    Int J Clin Exp Med 2019;12(12):13592-13600 www.ijcem.com /ISSN:1940-5901/IJCEM0098210 Original Article Changes in neurochemical metabolism measured by magnetic resonance spectroscopy and expression of the ERK signaling pathway in a rat model of depression Wei Zhang1,2,3, Caixia Yang2, Xianglin Li2, Tongshen Liu2, Huiqiong Luo2, Ning Mao4, Qi Zhang2, Bin Wang1,2 1Shandong Medical Imaging Research Institute, Shandong University, No. 324, Jingwu Road, Huaiyin District, Jinan 250021, Shandong Province, China; 2Binzhou Medical University, No. 346, Guanhai Road, Laishan District, Yantai 264003, Shandong Province, China; 3Dezhou University, No. 566, Daxue West Road, Decheng District, Dezhou 253023, Shandong Province, China; 4Yantai Yuhuangding Hospital, No. 20, Yuhuangding East Road, Zhifu District, Yantai 264000, China Received June 9, 2019; Accepted October 7, 2019; Epub December 15, 2019; Published December 30, 2019 Abstract: Objective: To explore the neurochemical metabolism in the brain of rats with chronic unpredictable mild stress (CUMS) using magnetic resonance spectroscopy (MRS). Methods: All rats were anesthetized and scanned in axial, sagittal, and coronal positions with a 7.0 T MRI. The signals of N-acetylaspartate (NAA), choline-containing compounds (CHO), glutamate (GLU), and myo-inositol (MI) were determined by PRESS sequence acquisition 1H spectra in the hippocampus and prefrontal cortex. After scanning, the target antigen was detected by immunohis- tochemistry (IHC). Results: The sucrose consumption in the model group was significantly decreased compared with the control group (P<0.05). The level and vertical scores of the model group in an open field experiment were significantly lower than the control group (P<0.05).
    [Show full text]
  • Store Name:Microsoft Authorized Store Store ID: AR106 Contact
    Store Name:Microsoft Authorized Store Store ID: AR106 Contact Name: Deng Hongbo Phone: 18953380824 Address: Floor 5, ZiBo Shopping Store, No.125 JinJing Street, ZhangDian District, Zibo, Shandong Province Postal Code: 255000 Store Name:Microsoft Authorized Store -Shandong Yinhao Information Technology Co., Ltd Store ID: AR146 Contact Name: Zheng Chenxiao Phone: 13370514476 Address: Q2007 Microsoft Store, No.1 gate of Huaqiang electronic world, Shanda Road, Lixia District, Jinan City Postal Code: 250013 Store ID: DSD01 Contact Name: Liu Jianqi Phone: 0534-2444111 Address: North Campus of No.5 Middle School, Lujia Street, Decheng District, Dezhou City, 100 meters to the east of the road Postal Code: 253000 Store ID: DSD02 Contact Name: Zhang Yu Phone: 0546-8555163 Address: No. 28, Xisan Road, Dongying District, Dongying City (2nd floor, 20 meters north of Industrial and Commercial Bank of North China, intersection of Xisan Road and Jinan Road) Postal Code: 257061 Store ID: DSD05 Contact Name: Xia Yang Phone: 0531-86421116 Address: Rm. 1115, Keyuan Building, Shanda Road Postal Code: 250014 Store ID: DSD06 Contact Name: Long Maoqiang Phone: 0537-2905079 Address: Jinyu road and road intersection southwest corner of pipa Postal Code: 272100 Store ID: DSD07 Contact Name: Yan Jiabao Phone: 0539-8367282 Address: West of Cross road of Tongda Road Postal Code: 276000 Store ID: DSD08 Contact Name: Geng Haifeng Phone: 0532-80687682 Address: Rm. 1507, Yinjie Shouzuo,153 Liaoning Road Postal Code: 266300 Store ID: DSD09 Contact Name: Liu Wei Phone: 0538-8251091 Address: West Xiaheqiao, Caiyuan Ave. Postal Code: 271000 Store ID: DSD10 Contact Name: Liu Chengkai Phone: 0536-2996911 Address: North Temple Street Broadcasting Digital Plaza, six floor 619 Postal Code: 261041 Store ID: DSD11 Contact Name: Lu Haiying Phone: 0631-5285566 Address: No.
    [Show full text]
  • 中國內地指定醫院列表 出版日期: 2019 年 7 月 1 日 Designated Hospital List in Mainland China Published Date: 1 Jul 2019
    中國內地指定醫院列表 出版日期: 2019 年 7 月 1 日 Designated Hospital List in Mainland China Published Date: 1 Jul 2019 省 / 自治區 / 直轄市 醫院 地址 電話號碼 Provinces / 城市/City Autonomous Hospital Address Tel. No. Regions / Municipalities 中國人民解放軍第二炮兵總醫院 (第 262 醫院) 北京 北京 西城區新街口外大街 16 號 The Second Artillery General Hospital of Chinese 10-66343055 Beijing Beijing 16 Xinjiekou Outer Street, Xicheng District People’s Liberation Army 中國人民解放軍總醫院 (第 301 醫院) 北京 北京 海澱區復興路 28 號 The General Hospital of Chinese People's Liberation 10-82266699 Beijing Beijing 28 Fuxing Road, Haidian District Army 北京 北京 中國人民解放軍第 302 醫院 豐台區西四環中路 100 號 10-66933129 Beijing Beijing 302 Military Hospital of China 100 West No.4 Ring Road Middle, Fengtai District 中國人民解放軍總醫院第一附屬醫院 (中國人民解 北京 北京 海定區阜成路 51 號 放軍 304 醫院) 10-66867304 Beijing Beijing 51 Fucheng Road, Haidian District PLA No.304 Hospital 北京 北京 中國人民解放軍第 305 醫院 西城區文津街甲 13 號 10-66004120 Beijing Beijing PLA No.305 Hospital 13 Wenjin Street, Xicheng District 北京 北京 中國人民解放軍第 306 醫院 朝陽區安翔北里 9 號 10-66356729 Beijing Beijing The 306th Hospital of PLA 9 Anxiang North Road, Chaoyang District 中國人民解放軍第 307 醫院 北京 北京 豐台區東大街 8 號 The 307th Hospital of Chinese People’s Liberation 10-66947114 Beijing Beijing 8 East Street, Fengtai District Army 中國人民解放軍第 309 醫院 北京 北京 海澱區黑山扈路甲 17 號 The 309th Hospital of Chinese People’s Liberation 10-66775961 Beijing Beijing 17 Heishanhu Road, Haidian District Army 中國人民解放軍第 466 醫院 (空軍航空醫學研究所 北京 北京 海澱區北窪路北口 附屬醫院) 10-81988888 Beijing Beijing Beiwa Road North, Haidian District PLA No.466 Hospital 北京 北京 中國人民解放軍海軍總醫院 (海軍總醫院) 海澱區阜成路 6 號 10-66958114 Beijing Beijing PLA Naval General Hospital 6 Fucheng Road, Haidian District 北京 北京 中國人民解放軍空軍總醫院 (空軍總醫院) 海澱區阜成路 30 號 10-68410099 Beijing Beijing Air Force General Hospital, PLA 30 Fucheng Road, Haidian District 中華人民共和國北京市昌平區生命園路 1 號 北京 北京 北京大學國際醫院 Yard No.1, Life Science Park, Changping District, Beijing, 10-69006666 Beijing Beijing Peking University International Hospital China, 東城區南門倉 5 號(西院) 5 Nanmencang, Dongcheng District (West Campus) 北京 北京 北京軍區總醫院 10-66721629 Beijing Beijing PLA.
    [Show full text]
  • Annual Report
    2019 ANNUAL REPORT (A joint stock company incorporated in the People’s Republic of China with limited liability) (H Shares Stock Code: 3866) (Preference Shares Stock Code: 4611) 2019 Contents Section I Important Notice, Contents and Definitions 3 Section II Corporate Information and Key Financial Highlights 6 Section III Chairman’s Statement 13 Section IV President’s Statement 14 Section V Business Overview 15 Section VI Discussion and Analysis of Operations 18 Section VII Significant Events 78 Section VIII Changes in Share Capital and Information on Shareholders 95 Section IX Preference Shares 105 Section X Directors, Supervisors, Senior Management and Employees 108 Section XI Corporate Governance 126 Section XII Report of the Board of Directors 150 Section XIII Report of the Board of Supervisors 157 Section XIV Independent Auditor’s Report 158 Section XV Financial Statements and Notes 165 Section XVI Unaudited Supplementary Financial Information 282 Bank of Qingdao Co., Ltd. 2 2019 Annual Report Section I Important Notice, Contents and Definitions 1. The Board of Directors, Board of Supervisors, Directors, Supervisors and senior management of the Bank assure that the information in this annual report contains no false records, misleading statements or material omissions, and severally and jointly take full responsibility for the authenticity, accuracy and completeness of the information in this annual report. 2. The proposals on the 2019 Annual Report of Bank of Qingdao Co., Ltd. and its summary were considered and approved at the 33rd meeting of the seventh session of the Board of Directors of the Bank held on 20 March 2020. There were 14 Directors eligible for attending the meeting, of whom 14 Directors attended the meeting.
    [Show full text]
  • Levi Strauss & Co. Factory List
    Levi Strauss & Co. Factory List Published : March 2019 Total Number of LS&Co. Parent Company Name Employees Country Factory name Alternative Name Address City State Product Type (TOE) Initiatives (Licensee factories are (Workers, Staff, (WWB) blank) Contract Staff) Argentina Accecuer SA Juan Zanella 4656 Caseros Accessories <1000 Capital Argentina Best Sox S.A. Charlone 1446 Apparel <1000 Federal Argentina Estex Argentina S.R.L. Superi, 3530 Caba Apparel <1000 Argentina Gitti SRL Italia 4043 Mar del Plata Apparel <1000 Argentina Manufactura Arrecifes S.A. Ruta Nacional 8, Kilometro 178 Arrecifes Apparel <1000 Argentina Procesadora Serviconf SRL Gobernardor Ramon Castro 4765 Vicente Lopez Apparel <1000 Capital Argentina Spring S.R.L. Darwin, 173 Apparel <1000 Federal Asamblea (101) #536, Villa Lynch Argentina TEXINTER S.A. Texinter S.A. Buenos Aires Apparel <1000 B1672AIB, Buenos Aires Argentina Vira Offis S.A. Virasoro, 3570 Rosario Apparel <1000 Plot # 246-249, Shiddirgonj, Bangladesh Ananta Apparels Ltd. Nazmul Hoque Narayangonj Apparel 1000-5000 WWB Ananta Narayangonj-1431 KASHPARA, NOYABARI, Bangladesh Ananta Denim Technology Ltd. Tariqul Islam Narayanganj Apparel 1000-5000 WWB Ananta KANCHPUR Ayesha Clothing Company Ltd (Ayesha Bangobandhu Road, Tongabari, Bangladesh Clothing Company Ltd,Hamza Trims Ltd, Ayesha Clothing Company Ltd Gazirchat Alia Madrasha, Dhaka Apparel 1000-5000 Hamza Clothing Ltd) Ashulia, Dhaka Jamgora, Post Office : Gazirchat Ayesha Clothing Company Ltd (Ayesha Ayesha Clothing Company Ltd (Ayesha Bangladesh Alia Madrasha, P.S : Savar, Dhaka Apparel 1000-5000 Washing Ltd.) Washing Ltd) Dhaka Khejur Bagan, Bara Ashulia, Bangladesh Cosmopolitan Industries PVT Ltd CIPL Dhaka Apparel 1000-5000 WWB Epic Designers Ltd Savar 1612, South Salna, Salna Bazar, Bangladesh Cutting Edge Washing Plant Md.
    [Show full text]
  • 2020 Annual Report Contents
    (A joint stock company incorporated in the People’s Republic of China with limited liability) (H Shares Stock Code: 3866) (Preference Shares Stock Code: 4611) 2020 ANNUAL REPORT Contents Section I Important Notice, Contents and Definitions 2 Section II Corporate Information and Key Financial Highlights 5 Section III Chairman’s Statement 12 Section IV President’s Statement 14 Section V Business Overview 17 Section VI Operation Discussion and Analysis 21 Section VII Significant Events 86 Section VIII Changes in Shareholdings and Information on Shareholders 102 Section IX Preference Shares 114 Section X Directors, Supervisors, Senior Management and Employees 116 Section XI Corporate Governance 129 Section XII Report of the Board of Directors 153 Section XIII Report of the Board of Supervisors 160 Section XIV Independent Auditor’s Report 161 Section XV Financial Statements and Notes 168 Section XVI Unaudited Supplementary Financial Information 286 Bank of Qingdao Co., Ltd. 2020 Annual Report 1 Section I Important Notice, Contents and Definitions 1. The Board of Directors, Board of Supervisors, Directors, Supervisors and senior management of the Bank assure that the information in this annual report contains no false records, misleading statements or material omissions, and severally and jointly take full responsibility for the authenticity, accuracy and completeness of the information in this annual report. 2. The proposals on the 2020 Annual Report of Bank of Qingdao Co., Ltd., its summary and the results announcement were considered and approved at the 44th meeting of the seventh session of the Board of Directors of the Bank held on 30 March 2021. There were 14 Directors eligible for attending the meeting, and 14 Directors actually attended the meeting.
    [Show full text]
  • Shandong WLAN Hotspot
    Shandong WLAN hotspot NO. SSID Location_Name Location_Type Location_Address City Province 1 ChinaNet Hanlin Hotel Hotels Jinan Jingshi Road 63 JiNan ShanDong 2 ChinaNet Liangyou Fulin Hotel Hotels Jinan City Luoyuan Avenue 5 JiNan ShanDong 3 ChinaNet Jardine Pearl International Hotel Hotels Jinan JinYi Road No. 88 JiNan ShanDong 4 ChinaNet Zhonghao Hotel Hotels Jinan City Lixia District Jiefang Road No. 165 JiNan ShanDong 5 ChinaNet Orient House Hotels Jinan City Central JinQi Road No. 223 JiNan ShanDong 6 ChinaNet Yuquan SinXinHotel Hotels Jinan Lixia District of City Luoyuan Street 68 JiNan ShanDong 7 ChinaNet Hill Garden Hotels Yangchun City ChunYang Hill Garden QingDao ShanDong 8 ChinaNet Ocean Hotel Hotels Qinling Road Ocean Hotel QingDao ShanDong 9 ChinaNet Beauty Hua Grand Hotel Hotels Shandong DeZhong DeCheng city liberation North No. 134 DeZhou ShanDong 10 ChinaNet The new lake business Bay Office Buiding DeZhou ShanDong 11 ChinaNet Home Hotel Hotels Shandong Dezhou City Commercial Street No. 81 DeZhou ShanDong 12 ChinaNet Texas Government Building Government Dezhou City Dongfanghong Road No. 64 DeZhou ShanDong 13 ChinaNet TianQu Industrial Park Industry Park Dezhou Hubin North Road DeZhou ShanDong 14 ChinaNet ICBC Building, Texas Office Buiding Dezhou TianQu East ICBC Building DeZhou ShanDong 15 ChinaNet Texas Agricultural Bank of China Building Office Buiding Dezhou City DeCheng District Commercial Street No. 72 DeZhou ShanDong 16 ChinaNet Texas Water Conservancy Bureau Building Government Dezhou City eCheng District 38Road 92 DeZhou ShanDong 17 ChinaNet Texas new Lake Plaza Others Dezhou City Lake Road new Lake Square DeZhou ShanDong 18 ChinaNet Texas College School Shandong Province Dezhou City University West Road No.2 DeZhou ShanDong 1/1.
    [Show full text]